VMD Earnings

VMD reported its earnings on 2026-05-05, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.09 by 0%. The stock experienced a -12.22% price change on the earnings day and a -6.91% change over the next five days, reflecting market reactions to the results.

Following VMD's earnings announcement on 2026-05-05, the stock price moved by -12.22% on the day of the release. Over the subsequent five days, it saw a -6.91% change. Historically, VMD's stock price tends to shift by an average of -2.96% in the 10 days leading up to earnings and -1.89% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate VMD's annual revenue to reach 81.90M, while the EPS is projected at 0.12. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between VMD's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, VMD's stock price typically moves by -2.96% in the 10 days before its earnings and -1.89% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.12 and revenue of 81.90M.

The company demonstrates strong financial performance with a 28% revenue increase and improved free cash flow. Despite regulatory challenges, the guidance is optimistic, supported by strategic growth in sleep and maternal health sectors. The share repurchase program signals confidence in long-term value. Positive sentiment is further reinforced by analysts' acknowledgment of potential upside in guidance. However, near-term pressures from NCD criteria and seasonal revenue patterns temper enthusiasm, resulting in a positive, yet moderate, stock price outlook.